Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients

Author： Sagara Yasuaki  

Publisher： Springer Publishing Company

ISSN： 1340-6868

Source： Breast Cancer, Vol.17, Iss.3, 2010-07, pp. : 212-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse bone effects during pharmacological breast cancer therapy

By Bjarnason Nina   Hitz Mette   Jorgensen Niklas   Vestergaard Peter  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 747-754

Informa Healthcare

Access to resources Recommend Favorite

A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06)

By Takeuchi Hideki   Takei Hiroyuki   Futsuhara Kazushige   Yoshida Takashi   Kojima Makoto   Kai Toshihiro   Tabei Toshio  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 68-73

Springer Publishing Company

Access to resources Recommend Favorite

Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer

By Sawada Shojiro   Sato Kazuhiko   Kusuhara Masatoshi   Ayaori Makoto   Yonemura Atsushi   Tamaki Kuniyoshi   Hiraide Hoshio   Mochizuki Hidetaka   Ohsuzu Fumitaka  

Acta Oncologica, Vol. 44, Iss. 2, 2005-03 ,pp. : 134-141

Informa Healthcare

Access to resources Recommend Favorite

Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

By Kyvernitakis I.   Knöll D.   Struck M.   Hars O.   Bauer T.   Hadji P.  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

By Kurosumi Masafumi   Takatsuka Yuichi   Watanabe Toru   Imoto Shigeru   Inaji Hideo   Tsuda Hitoshi   Akiyama Futoshi   Sakamoto Goi   Ikeda Tadashi   Noguchi Shinzaburo  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 6, 2008-06 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite